hepatitis bcasebased hepatitis b management
home
spacer
meds.com
spacer
Hepatitis Information Center
spacer
Sponsored by Postgraduate Institute for Medicine
Supported by GlaxoSmithKline
spacer
M401

53yo Vietnamese woman with abnormal liver test


spacer
Go BackdividerContinuespacer

Dr. Perrillo (OC): In this instance, we chose lamivudine therapy because it's more potent actually than adefovir. And it is also significantly cheaper. Lamivudine mono therapy costs about $150.00 US dollars per month. Whereas with adefovir, it's about $550 to $600.00. So there was a consideration of financial cost. We also felt that if the patient developed lamivudine resistance, we could roll the patient over to adefovir therapy at that time.... In fact, many authorities tend to go with this approach.